Medical Device Regulation in Saudi Arabia
Saudi Arabia regulates medical devices through the Saudi Food and Drug Authority (SFDA), which manages the entire lifecycle from market authorization to post-market surveillance. The SFDA Medical Device Interim Regulations (MDIR) establish a comprehensive regulatory framework. Saudi Arabia is the largest medical device market in the Middle East and has been progressively strengthening its regulatory standards.
Recent Regulatory Updates
Showing the latest 3 updates. Sign up to see more
SFDA releases 2025 medical device inspection stats
SFDA updates inspection, QMS, and personnel requirements.
New third-party storage rules, updated requirements.
Sources Tracked by Qalico
Qalico continuously monitors 44 references across guidelines, regulations, and standards for Saudi Arabia.
Regulations
Guidelines
Device Classification
Saudi Arabia uses a four-tier risk-based classification system aligned with GHTF/IMDRF principles. Class I devices are low risk (e.g., manual surgical instruments, elastic bandages). Class II devices are low-moderate risk (e.g., powered wheelchairs, pregnancy test kits). Class III devices are moderate-high risk (e.g., orthopedic implants, hemodialysis systems). Class IV devices carry the highest risk (e.g., pacemakers, coronary stents, drug-eluting devices).
Official classification guidance →Official Guidance Documents
Official page for medical device regulatory requirements, guidance documents, and circulars issued by SFDA.
Portal for medical device market authorization applications and facility registration in Saudi Arabia.
Information on adverse event reporting and vigilance requirements for medical devices in Saudi Arabia.
Standards & Key Principles
Applicable Standards
Key Principles
- All medical devices must be listed with SFDA before being marketed in Saudi Arabia.
- Manufacturing and distribution facilities must be registered with SFDA.
- An in-country Saudi Authorized Representative (SAR) is required for foreign manufacturers.
- SFDA accepts CE marking, FDA clearance/approval, and other recognized regulatory approvals as part of the review process.
- Arabic language labeling is mandatory for medical device products sold in Saudi Arabia.
- Classification follows a four-tier risk-based system aligned with GHTF/IMDRF guidelines.
Pre-Market Requirements
All medical devices require SFDA market authorization through the Medical Device Marketing Authorization process. Applications are submitted via the SFDA electronic portal.
Manufacturing, import, and distribution facilities must be registered with SFDA and maintain compliance with applicable quality system requirements.
Manufacturers must provide evidence of conformity including ISO 13485 certification and, where applicable, CE certificates or FDA clearance/approval as supporting evidence.
Foreign manufacturers must appoint a Saudi Authorized Representative responsible for regulatory compliance and communication with SFDA.
Post-Market Requirements
Mandatory reporting of adverse events, near-incidents, and field safety corrective actions to SFDA within specified timeframes.
Listing holders must maintain a post-market surveillance system and submit periodic reports to SFDA.
SFDA must be notified of all field safety corrective actions including recalls, and the authority may initiate mandatory recalls when necessary.
Device listings must be renewed periodically, requiring updated compliance documentation and PMS data.
International Recognition & Reliance
SFDA is an affiliate member of the International Medical Device Regulators Forum and aligns its regulatory practices with IMDRF guidance.
Saudi Arabia participates in Gulf Cooperation Council regulatory harmonization efforts for medical devices.